FDA Adverse Event Injury Summary report: N

LARGE MOD HEAD ADAPT 12/14 +5

MDR report key: 2801378 · Received October 23, 2012

Report

Report Number
1818910-2012-77035
Event Type
Injury
Date Received
October 23, 2012
Date of Event
August 29, 2012
Report Date
June 19, 2015
Manufacturer
DEPUY INTL., LTD. - 8010379
Product Code
KWA
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED. THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY.

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. DEPUY STILL CONSIDERS THIS CASE CLOSED TO CAPA. (B)(4).

Description of Event or Problem · 1

ASR REVISION; ASR XL - LEFT; REASON FOR REVISION: UNKNOWN.

Description of Event or Problem · 1

NEW ETQ RECORD CREATED IN ORDER TO UPDATE ETQ (LEGACY SYSTEM) COMPLAINT NUMBER (B)(4) REASON FOR ORIGINAL COMPLAINT ¿ ASR REVISION TO TAKE PLACE ON (B)(6) 2012, ASR XL - LEFT, REASON(S) FOR REVISION: UNKNOWN. BI-LATERAL - SEE (B)(4) FOR RIGHT HIP. UPDATE: ADDED PRODUCT AND DATE OF REVISION. RECEIVED: (B)(6) 2012. (B)(6) 2015 - UPDATE - RCVD REASON FOR REVISION: ALVAL / SOFT TISSUE REACTION, STATES NO CODES AVAILABLE FOR STEM.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 LARGE MOD HEAD ADAPT 12/14 +5 HIP FEMORAL STEM/SLEEVE KWA DEPUY INTL., LTD. - 8010379 1201135

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention